🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10288+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10288 recruiting trials

Phase 2RecruitingNCT07208981

Orelabrutinib Combined With Zebetuzumab and Lenalidomide for the Treatment of Newly Diagnosed MZL

🏥 The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Aug 2025View details ↗
NAEnrolling by InvitationNCT07401498

Complications Associated With Lymphadenectomy (LAD) in Surgical Treatment of Non-small Cell Lung Cancer (NSCLC).

🏥 Regional Clinical Oncology Dispensary📍 1 site📅 Started Aug 2025View details ↗
EARLY_Phase 1RecruitingNCT07076472

Sonodynamic Therapy With SONALA-001 or 5-ALA HCL and Magnetic Resonance Guided Focused Ultrasound for the Treatment of Progressive or Recurrent Glioblastoma

👨‍⚕️ Terence C. Burns, MD, PhD, Mayo Clinic📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07135544

A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer

🏥 Yongjun Chen📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07130032

Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade

👨‍⚕️ Sergey V. Orlov, Professor, EuroCityClinic LLC📍 1 site📅 Started Aug 2025View details ↗
Enrolling by InvitationNCT07217509

PPDTM CorEvitasTM Myasthenia Gravis (MG) Drug Safety and Effectiveness Registry

🏥 CorEvitas📍 1 site📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT06735664

Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation

👨‍⚕️ Alexey V Danilov, City of Hope Medical Center📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07100392

Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab

🏥 Fudan University📍 1 site📅 Started Aug 2025View details ↗
RecruitingNCT07098650

Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

🏥 Perspectum📍 1 site📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT06948318

A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

👨‍⚕️ Study Director, Takeda📍 97 sites📅 Started Aug 2025View details ↗
NARecruitingNCT07192705

Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)

👨‍⚕️ Naif S Sulaiman, PhD Candidate📍 1 site📅 Started Aug 2025View details ↗
Enrolling by InvitationNCT07163156

Prolactin, Inflammation, and Parkinson's Severity

🏥 Çanakkale Onsekiz Mart University📍 1 site📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07105709

Open-label Extension Study in Participants With Early Alzheimer's Disease

👨‍⚕️ GSK Clinical Trials, GlaxoSmithKline📍 33 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06661915

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

👨‍⚕️ Anand A Patel, City of Hope Comprehensive Cancer Center LAO📍 25 sites📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT07123519

A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases

🏥 China Immunotech (Beijing) Biotechnology Co., Ltd.📍 1 site📅 Started Aug 2025View details ↗
Phase 1RecruitingNCT07082868

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

👨‍⚕️ Christian Grommes, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT07030699

A Study of Epcoritamab With Lenalidomide and Tafasitamab in People With Diffuse Large B Cell Lymphoma

👨‍⚕️ Pallawi Torka, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2025View details ↗
Phase 3RecruitingNCT07059000

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

👨‍⚕️ Mirella Calcinai, MD, Kedrion S.p.A.📍 27 sites📅 Started Aug 2025View details ↗
Phase 4RecruitingNCT06864403

Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch

👨‍⚕️ Edward Barnes, MD, MPH, University of North Carolina📍 5 sites📅 Started Aug 2025View details ↗
Phase 2RecruitingNCT06453694

Efgartigimod for the Treatment of Acute Optic Neuritis

👨‍⚕️ Anastasia Vishnevetsky, MD, MPH, Massachusetts General Hospital📍 2 sites📅 Started Aug 2025View details ↗
← PreviousPage 76 of 515Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →